Clinical Trial Update: Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention [NA]

View source ↗

Summary

A clinical trial update comparing an ultra-low strut thickness everolimus-eluting biodegradable polymer stent with a durable polymer everolimus-eluting stent in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• Durable polymer everolimus-eluting stent (everolimus-eluting stent with durable polymer)
• Ultra-low strut thickness everolimus-eluting biodegradable polymer stent (everolimus-eluting stent with biodegradable polymer)

Snippet

Sponsor: Odense University Hospital | Conditions: Ischemia, Myocardial, Coronary Artery Disease | NA | Status: RECRUITING